![L-R: Managing Director, BGL Securities Limited, Arnold A. Dublin-Green; Assistant Vice President, Financial Derivatives Limited, Dr. Ifeoma Nwokolo; CEO, Centre for the Promotion of Private Enterprise [CPPE], Muda Yusuf (speaker); Chairman of the Occasion, Chief Paul Usoro; Dean, Lagos Business School, Information Systems, Prof. Olayinka David-West; Managing Director/CEO, Financial Derivatives Company, Bismarck Rewane; Group Chief Branding & Communications Officer, Dangote Industries Limited, Anthony Chiejina at Dangote Petroleum Refinery & Petrochemicals IPO Roadshow tagged “Back to where it all began” in Port Harcourt. Rivers State on Monday, October 12, 2026…](https://pmparrotng.com/wp-content/uploads/2026/10/Dangote-imagee-180x135.jpg "As Dangote Refinery’s IPO Nears Close, Small Investors Take Center Stage")
The Lagos State Commissioner for Health, Prof. Akin Abayomi, has said the state has concluded plans to start COVID-19 clinical trial in partnership with the Nigeria Centre for Disease Control and other institutions.
He said, “There are a lot of research going on around the world, so it is possible that at some time in the near future, we will have what we may describe as a definitive cure for COVID-19. Indeed we are setting up our own clinical trials in Lagos in collaboration with other institutions and the NCDC and hopefully by this time next week, we should have started some clinical trials on our patients and on our staff in Lagos State.
“We have three testing sites in Lagos and we are looking to activate some other sites. The current three are Lagos State Biobank at Yaba Mainland Hospital, Department of Virology in the Lagos University Teaching Hospital and the Nigerian Institute of Medical Research.”
Credit: punchng.com
